After-Hours Stock Movers: INTC, AMD, ARM, MXL, EW, DECK By Investing.com
After-hours movers followed a Nasdaq drop tied to Alphabet and Tesla. Intel (INTC) rose 12% after Q2 EPS of $0.42 on $16.13B revenue, with Q3 revenue guidance of $15.8B to $16.8B. AMD and Arm gained on the news. MaxLinear (MXL) fell 7% despite Q2 and strong Q3 guidance. Deckers (DECK) slipped 3%, Edwards Lifesciences (EW) rose 6%.
How this was made
The 30-second read
Why it matters
The newest actionable facts are the specific EPS/revenue beats and the explicit Q3 or full-year guidance ranges, which explain the direction and magnitude of after-hours moves for each named company.
Market read
Traders can use the guidance ranges to update near-term expectations and manage gap risk into the next regular session.
What to watch
The article does not quantify margins, backlog, or order trends; traders may need to verify whether the guidance implies sustainable demand versus temporary channel fill.
Background
This is an after-hours stock-movers wrap tied to Q2 earnings reactions and forward guidance across semiconductors, optical networking, consumer footwear, and medical devices.
Ticker impact
Intel jumped 12% after Q2 EPS of $0.42 beat estimates and guided Q3 revenue to $15.8–$16.8B, signaling AI-driven momentum.
Likely near-term volatility with a bias to follow-through if investors buy the guidance, but profit-taking risk remains after a +12% after-hours move.
The article provides concrete EPS/revenue beats and a specific Q3 revenue range, which typically drives immediate repricing and can extend into the next session.
MaxLinear fell 7% despite Q2 estimate topping, as Q3 revenue guidance of $210–$220M was viewed as insufficient versus expectations.
Near-term downside pressure or choppy trading as traders reassess the optical data center demand outlook after guidance.
The article includes both the beat and the specific Q3 revenue range, and explicitly ties the selloff to the mixed reaction after a large pre-earnings run.
Deckers Brands dropped 3% after a modest Q1 beat, but full-year fiscal 2027 EPS guidance of $7.35–$7.50 matched expectations.
Limited upside follow-through unless subsequent quarters show acceleration beyond the conservative outlook.
The article provides the beat and the guidance range, and attributes the decline to lack of a clear beat-and-raise, which often caps immediate re-rating.
Edwards Lifesciences gained 6% after Q2 adjusted EPS of $0.78 beat forecasts, reaffirming full-year EPS $2.95–$3.05 and issuing upbeat Q3 targets.
Potential for continued strength into the next session if investors treat TAVR procedure growth as durable.
The article includes explicit EPS beats, reaffirmed full-year range, and specific Q3 EPS targets, which are direct drivers of earnings-multiple repricing.
Market effects
Intel’s AI-driven CPU and foundry momentum narrative can lift broader PC/server chip sentiment, while MaxLinear’s optical data center guidance sensitivity highlights demand expectations in high-speed interconnects.
Primarily US after-hours single-name repricing; broader Nasdaq weakness is attributed to mega-cap drags and oil, not these prints alone.
Oil price strength and US tech risk appetite can influence global semiconductor and medical device risk premia, but the article’s actionable content is company-specific earnings guidance.
Counterpoint
After-hours big moves may reverse if investors were already positioned for a beat; guidance interpretation can be more important than the headline EPS beat.
Key entities
- companyIntel
Q2 EPS and revenue beat plus Q3 revenue guidance cited as the driver of a +12% after-hours jump.
- companyMaxLinear
Q2 beat paired with Q3 revenue guidance that triggered a -7% after-hours drop.
- companyDeckers Brands
Q1 modest beat but full-year fiscal 2027 guidance described as matching expectations, leading to a -3% move.
- companyEdwards Lifesciences
Q2 adjusted EPS beat with reaffirmed full-year guidance and upbeat Q3 EPS targets, leading to a +6% move.
